New York Life Investment Management LLC reduced its position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 0.3% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 60,837 shares of the medical device company’s stock after […]
/PRNewswire/ The "Diagnostics and Therapeutics for HIV: Global Markets" report has been added to ResearchAndMarkets.com s offering. The global diagnostics.
Pinnacle Financial Partners Inc reduced its stake in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 30.9% in the second quarter, according to its most recent filing with the SEC. The fund owned 48,062 shares of the medical device company’s stock after selling 21,507 shares during the period. Pinnacle Financial Partners Inc’s holdings in […]
Addressing the Global HIV Challenge: Market for Diagnostics and Therapeutics Plays a Crucial Role in Combating HIV/AIDS lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.
Impax Asset Management Group plc reduced its position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 5.5% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 331,445 shares of the medical device company’s stock after selling 19,420 shares during the period. Impax Asset […]